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Abstract
Entry into and progression through mitosis depends on phosphorylation and dephosphorylation of key substrates. In yeast,
the nucleolar phosphatase Cdc14 is pivotal for exit from mitosis counteracting Cdk1-dependent phosphorylations. Whether
hCdc14B, the human homolog of yeast Cdc14, plays a similar function in mitosis is not yet known. Here we show that
hCdc14B serves a critical role in regulating progression through mitosis, which is distinct from hCdc14A. Unscheduled
overexpression of hCdc14B delays activation of two master regulators of mitosis, Cdc25 and Cdk1, and slows down entry
into mitosis. Depletion of hCdc14B by RNAi prevents timely inactivation of Cdk1/cyclin B and dephosphorylation of Cdc25,
leading to severe mitotic defects, such as delay of metaphase/anaphase transition, lagging chromosomes, multipolar
spindles and binucleation. The results demonstrate that hCdc14B-dependent modulation of Cdc25 phosphatase and Cdk1/
cyclin B activity is tightly linked to correct chromosome segregation and bipolar spindle formation, processes that are
required for proper progression through mitosis and maintenance of genomic stability.
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Introduction
Cdk1/cyclin B is the central kinase that promotes entry into and
progression through early stages of mitosis by triggering a variety
of mitotic events, such as breakdown of the nuclear envelope,
condensation of chromosomes, and assembly of the mitotic spindle
[1–3]. During interphase, Cdk1 activity is downregulated by
Wee1- and Myt1-dependent phosphorylation of conserved
threonine T14 and tyrosine Y15 residues in the ATP-binding
domain of Cdk1 [1]. Activation of Cdk1/cyclin B is achieved by a
complex mitotic entry network, which consists of several feedback
loops. Through a central feedback loop Cdk1 is activated by
Cdc25-dependent dephosphorylation at pT14/pY15. Once acti-
vated, Cdk1/cyclin B phosphorylates Cdc25 phosphatases as well
as Myt1 and Wee1 kinases, augmenting Cdc25 activity and
repressing Myt1 and Wee1. Cdk1/cyclin B activity and mitotic
entry are further controlled by additional superimposed feedback
mechanisms upregulating the mitotic kinases Plk1 and Aurora A,
and the Aurora/Plk1 activator Bora, coupling mitotic entry to
centrosome maturation, and stimulating expression of proteins of
the mitotic entry network, such as cyclin B [4].
Cdc25 phosphatases are highly conserved among eukaryotes.
The three isoforms of mammalian Cdc25, A, B and C, are all
regulated by reversible phosphorylation, phosphorylation affecting
their enzymatic activity, intracellular localisation and stability
[5–9]. Consistent with the notion that phosphorylation-dependent
activation of Cdc25s is part of the central positive feedback
amplification loop that increases Cdk1/cyclin B activity and
promotes entry into mitosis, ablation of Cdc25A and B delays G2/
M transition [8–10], whereas overexpression induces premature
activation of Cdk1 and accelerates entry into mitosis [8,10–11]. In
contrast to Cdc25A and B, Cdc25C alone is not sufficient for
mitotic entry [10]. During M/G1 transition down-regulation of
Cdk1 activates Wee1 and Myt1 kinases and inhibits Cdc25
phosphatases [12]. Thus, completion of mitosis depends on
dephosphorylation and inactivation of Cdc25 and Cdk1/cyclin
B as well as reversal of Cdk1/cyclin B-dependent phosphoryla-
tions.
In budding yeast, yCdc14 antagonizes the action of mitotic
Cdks, triggering the degradation of mitotic cyclins and regulating a
variety of mitotic events, such as spindle dynamics, rDNA
segregation and cytokinesis [13–18]. yCdc14 is sequestered in
the nucleolus during interphase and is activated upon release from
the nucleolus at anaphase [19–20]. Mammalian cells express two
isoforms of Cdc14, the cytoplasmic phosphatase hCdc14A and the
nucleolar phosphatase hCdc14B [21], both of which target
proteins that are phosphorylated by proline-directed kinases
[22]. Despite their evolutionary conservation, the physiological
role of mammalian Cdc14 phosphatases is poorly understood.
Several functions have been assigned to human Cdc14A
(hCdc14A), including centrosome splitting, mitotic spindle forma-
tion, and chromosome segregation [23–24]. Few physiological
substrates of hCdc14A have been identified, e.g. SIRT2 [25], Erk3
[26], and the Rab5 GTPase-activator RN-tre [27]. Mammalian
Cdc14B (hCdc14B), like its yeast counterpart, is sequestered in
nucleoli during interphase and released during mitosis [23–24,28].
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e14711Release from the nucleolus is also triggered by the G2-DNA
damage checkpoint leading to hCdc14B-induced activation of
APC/C
Cdh1 [29]. Moreover, both hCdc14A and hCdc14B have
been implicated in centriole amplification [30] and DNA repair
[31]. Given the evolutionary conservation of basic biological
mechanisms, one would anticipate that hCdc14B, like yCdc14,
controls processes that trigger progression through mitosis. In
support of this view, hCdc14B has been shown to modulate the
assembly and disassembly of the mitotic spindle by bundling and
stabilizing microtubules, yet apparently independent of its catalytic
activity [28]. In addition, hCdc14B reverses mitotic phosphory-
lations on SIRT2 and Skp2, thereby triggering proteasome-
dependent degradation of these proteins, and promoting mitotic
exit and entry into G1-phase [25,32].
In this study, we have examined the role of hCdc14B during
mitosis. We show that hCdc14B is associated with nucleolar
chromatin during interphase, released at prometaphase and
rebound in early G1. RNAi-induced depletion of hCdc14B causes
errors in chromosome segregation, metaphase delay, multipolar
spindles, and cell death due to accumulation of multiple mitotic
defects. hCdc14B dephosphorylates and inactivates the mitotic
inducer Cdc25, enabling efficient inactivation of Cdk1 at late M-
phase. Together, our results show for the first time that hCdc14B
serves an important role in mitotic progression, regulating the
activity of Cdc25s and Cdk1/cyclin B.
Results
Unscheduled Expression of hCdc14B disturbs Timing of
Mitosis
Immunofluorescence studies have demonstrated that hCdc14B
localizes within nucleoli in interphase cells [23,28]. Fractionation of
extracts from synchronized HeLa Kyoto cells that stably express
GFP-tagged histone H2B (H2B-GFP) showed that hCdc14B was
associated with chromatin during interphase and was released into
the soluble fraction at prometaphase (Fig. 1A). Re-association with
chromatin started around telophase and was completed after
decondensation of chromatin in early G1 (Fig. 1A, right panels and
bottom images). In contrast, virtually all hCdc14A was contained in
the soluble cytoplasmic fraction throughout the cell cycle and was
not detectable in the nucleoplasmic or chromatin fraction (Fig. 1A).
The cell cycle-dependent, dynamic interaction of hCdc14B with
nucleolar chromatin suggests that nucleolar sequestration serves a
regulatoryfunction incycling cellssimilarto yeastCdc14,restricting
hCdc14B activity from early mitosis to telophase.
To examine a potential role of hCdc14B in mitosis, we
generated U2OS cell lines that conditionally express Flag-tagged
hCdc14B (U2OS-fl-hCdc14B) or the catalytically inactive mutant
(U2OS-fl-hCdc14B
SL). Clonal cell lines were synchronized by
double thymidine block, hCdc14B expression was induced
concomitant with release from the G1/S arrest (Supp. Fig. S1)
and cell cycle progression was determined by flow cytometry
analyses (FACS) (Fig. 1B). The FACS profiles were similar in
parental and fl-hCdc14B cell lines until the cells reached the G2/
M-phase (12 h after release), indicating that overexpression of
wildtype or mutant hCdc14B had not affected progression through
S- and G2-phase. However, re-entry into the next G1-phase was
delayed in cells expressing fl-hCdc14B. While in parental cells
progression through G2/M-phase and entry into the next G1-
phase was completed after 16–18 h, a significant fraction of cells
expressing fl-hCdc14B (38%) and fl-hCdc14B
SL (21%) were still in
G2/M 16 h after release indicating aberrant timing of mitosis.
To investigate whether delayed re-entry into G1 was due to
delay in mitotic entry or prolonged mitosis, we monitored the
phosphorylation state of pY15-Cdk1 on immunoblots. In parental
and U2OS-fl-hCdc14B
SL cells, pY15-Cdk1 phosphorylation was
low at 12 h after release from G1/S, consistent with a timely entry
into mitosis. In contrast, in cells overexpressing wildtype fl-
hCdc14B, pY15 levels remained elevated up to 13 h (Fig. 1C).
This suggests that increased levels of hCdc14B prevented timely
dephosphorylation and activation of Cdk1, thereby delaying entry
into mitosis. Consistent with the FACS data showing prolonged
G2/M and delayed entry into G1, there was no de novo
phosphorylation of Cdk1 up to 18 h after release from G1/S in
fl-hCdc14B cells. Moreover, cell proliferation was reduced in
clonal cell lines expressing fl-hCdc14B, proliferation inversely
correlating with the level of ectopic fl-hCdc14B (Supp. Fig. S2A
and B). In contrast, overexpression of mutant fl-hCdc14B
SL did
not impair dephosphorylation of Cdk1 on Y15, but mitotic
phosphorylation of H3-pSer10 was extended over a longer period
of time (3 h compared to parental cells) (Fig. 1C), indicating that
either progression through mitosis or mitotic exit were delayed.
Depletion of hCdc14B Impairs Progression through
Mitosis
Given that overexpression of hCdc14B impaired progression
through mitosis, we next analyzed the mitotic phenotype caused
by ablation of hCdc14B. Treatment of HeLa Kyoto cells with
hCdc14A- or hCdc14B-specific siRNAs for 72 h reduced the level
of hCdc14A- or hCdc14B-mRNAs to 35–60% (Fig. 2D). Immu-
nofluorescence analysis of cycling cells treated with Cdc14A- or
Cdc14B si-RNAs revealed that pSer10-H3-positive, mitotic cells
were enriched up to 3-fold upon depletion of hCdc14B compared
to cells treated with control siRNA or hCdc14A-specific siRNA
(Fig. 2A and C). hCdc14A- and hCdc14B-specific siRNAs caused
a drop in the overall cell number (data not shown), suggesting that
both isoforms are required for proper cell proliferation. Consistent
with results of Mailand et al. [24], the number of bi- and
multinucleated cells was significantly increased in hCdc14A-
deficient cells (Fig. 2B and C). Notably, binucleation was also
observed upon knockdown of hCdc14B, albeit at lower frequency
compared to hCdc14A-depleted cells (Fig. 2B and C). This
suggests that knockdown of hCdc14A primarily perturbed
cytokinesis without affecting progression through mitosis, whereas
depletion of hCdc14B also impaired events required for
progression through mitosis depletion increasing the amount of
mitotic cells.
We next examined mitotic progression upon depletion of
hCdc14B in synchronized HeLa Kyoto cells (Fig. 3A). After
release from the second G1/S-arrest, progression into mitosis was
monitored by live microscopy visualizing chromosome condensa-
tion via H2B-GFP-labeled chromatin. Representative images of
the phenotypic responses from RNAi with an hCdc14B-specific
siRNA are shown in Figure 3B. Cells entered mitosis 12 h after
release, regardless whether or not hCdc14B was depleted. While
most of control cells re-entered a new division cycle at 16 h after
release from G1/S, a significant proportion (48%) of hCdc14B-
depleted cells was enriched in metaphase (Fig. 3B and Table 1),
suggesting that hCdc14B activity is required for successful
completion of mitosis. Consistent with the delay of metaphase to
anaphase transition, prolonged mitotic hyperphosphorylation of
Cdc27/APC3 [33] was observed (Fig. 3C). Moreover, 24 h after
release a large number of hCdc14B-siRNA treated cells stained
positive in the TUNEL assay with cleavage of PARP-1 (Fig. 3D
and Table 1), indicating that the strong delay in mid-/late-mitosis
has triggered apoptosis. Again and consistent with knockdown of
hCdc14B in non-synchronized cells (Fig. 2), the amount of bi- and
multinucleated cells was increased (Supp. Fig. S3 and Table 1).
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PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e14711Figure 1. Overexpression of hCdc14B alters progression through mitosis. A. hCdc14B is released from chromatin in early mitosis and is
rebound in late M/early G1. HeLa cells expressing histone H2B-GFP (HeLa Kyoto) were arrested at G1/S by double thymidine-block (left) or at
prometaphase of mitosis by nocodazole (right), and released for the indicated times. Release from nocodazole (nocod.) arrest was monitored
visualizing H2B-GFP labelled chromatin (bottom panel). Synchronized cells were fractionated into cytoplasm (cyt.), nucleoplasm (nucl.) and chromatin
(chr.), and analyzed on immunoblots for the proteins indicated (top panels). B. Overexpression of hCdc14B prolongs G2/M-phase. FACS of U2OS,
U2OS-fl-hCdc14B and U2OS-fl-hCdc14B
SL cells following release from G1/S (0 h) upon induction of hCdc14B expression by doxycyclin (Fig. S1). Cell
numbers were calculated using the Cell Quest software program. The percentage of cells at the indicated cell cycle phases is presented. C.
Overexpression of hCdc14B affects mitotic progression. Immunoblots showing the abundance of specific cell cycle marker proteins at distinct time
points (h) after release from G1/S.
doi:10.1371/journal.pone.0014711.g001
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hCdc14B impairs metaphase-anaphase transition mitotic delay
leading to cell death.
Silencing of hCdc14B Causes Chromosome
Mis-segregation and Multipolar Spindles
To investigate whether silencing of hCdc14B had perturbed
spindle assembly or chromosome segregation, immunofluores-
cence microscopy was performed with CREST and anti-alpha-
tubulin antibodies. Immunostaining of mitotic spindles in U2OS
cells depleted of hCdc14B by hCdc14B-shRNA-2 or hCdc14B-
shRNA-3 (Fig. 4E) revealed multi-polar spindles at frequencies
that were significantly higher (24–28%) than in cells transfected
with an unrelated Ctrl-shRNA (2.5%). Most of the aberrant
spindles were tri- or tetrapolar (Fig. 4A and D), although some
cells with even more than 5 spindle poles were observed. In
addition, hCdc14B-depletion increased the number of bipolar
anaphase cells with lagging chromosomes (18–25%), indicative of
chromosome missegregation (Fig. 4B and D). Again, while
frequency of binucleation was low in control cells, it was
significantly elevated in hCdc14B-depleted cells (Fig. 4C). These
analyses indicate that silencing of hCdc14B caused problems in
proper segregation of chromosomes, which in turn may explain
the delay in mid-mitosis observed in HeLa Kyoto cells depleted of
hCdc14B (see Fig. 3), and caused defects in bipolar mitotic spindle
assembly, which is consistent with previous studies demonstrating
a role of hCdc14B in bundling of microtubules [28] and in
centriole amplification [30].
hCdc14B Regulates Cdk1/Cyclin B Activity
Reversal of mitotic Cdk1-dependent phosphorylations and
inhibition of Cdk1 are hallmarks of Cdc14 function in yeast
[18,34]. To decipher a functional link between human Cdc14B
and Cdk1/cyclin B, we examined whether changes in hCdc14B
levels would affect Cdk1 activity. For this, we compared activation
of Cdk1/cyclin B in U2OS cell lines conditionally expressing fl-
hCdc14B or fl-hCdc14B
SL. After induction of wildtype or mutant
fl-hCdc14B in G1/S arrested cells (0 h), kinase activity of
immunopurified Cdk1/cyclin B was assayed at distinct times after
release. In parental cells, Cdk1/cyclin B activity reached maximal
Figure 2. Silencing of hCdc14B leads to enrichment of mitotic cells. HeLa Kyoto cells were reverse transfected twice with a control-siRNA
pool (siCtrl) or siRNAs that target hCdc14A (si14A) [24, Reference S1] or hCdc14B (si14B-3). During the second transfection equal numbers of cells
were seeded onto coverslips, and 24 h after the second transfection cells were subjected to immunofluorescence microscopy and analysis of hCdc14
expression. A, B. Representative immunofluorescence images of HeLa Kyoto cells transfected with siCtrl, si14A, or si14B-3. Mitotic cells were
visualized by immunostaining with histone H3-phospho-Serine-10 (pSer10-H3) antibodies (red) (A), multinucleated cells by staining with anti-alpha-
tubulin antibodies (red) (B). DNA was counterstained with Hoechst 33342. C. Frequencies of mitotic and multinucleated cells. The data shown here
represent means (6SD) of three independent experiments derived from counting 400 cells each. D. hCdc14A and hCdc14B expression is reduced by
the corresponding siRNAs. The graphs represent the mean levels (6SD) of hCdc14A-mRNA (light bar) and hCdc14B-mRNA (dark bar) normalized to b-
actin-mRNA as determined by RT-qPCR in three independent experiments.
doi:10.1371/journal.pone.0014711.g002
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PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e14711Figure 3. Depletion of hCdc14B impairs progression through mitosis and triggers apoptosis. A. Cell synchronization and specificity of
hCdc14B knockdown by siRNAs. HeLa Kyoto cells were reverse transfected with a control siRNA pool (siCtrl), siRNAs that target GFP-mRNA (siGFP), or
three different regions of hCdc14B-mRNA (siCdc14B-1, -2, -3; see Table S1 for sequence information) and synchronized as shown in the scheme. 8 h
after release from the second G1/S arrest, cells were lysed and the amount of hCdc14B, hCdc14A, H2B-GFP, and actin was analyzed on immunoblots.
B. Phase contrast and H2B-GFP fluorescence images of HeLa Kyoto cells that were transfected with control-siRNA (siCtrl) or hCdc14B-siRNA (siCdc14B-
3) and released from G1/S according to the scheme above. Before the second G1/S arrest, equal numbers of cells were seeded onto coverslips. The
Cdc14B Phosphatase and Mitosis
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degradation (Fig. 5A, left). In contrast and consistent with data
shown in Figure 1B, activation of Cdk1 was delayed in cells
expressing fl-hCdc14B, reaching maximal levels at 15 h, which
declined more slowly than in parental cells (Fig. 5A, middle). The
delay in Cdk1 activation correlated with elevated levels of pY15
(Fig. 5A, middle). Cdk1 activity was high over an extended period
in cells expressing the catalytically inactive mutant fl-hCdc14B
SL
(Fig. 5A, right), suggesting that hCdc14B phosphatase is required
for timely inactivation of Cdk1/cyclin B.
To further corroborate this result, Cdk1/cyclin B activity was
measured in synchronized cells depleted of hCdc14B. Treatment
with hCdc14B-siRNAs increased Cdk1/cyclin B activity almost 2-
fold compared to control (Fig. 5B). Consistent with hCdc14B
promoting activation of APC
Cdh1 [29], cyclin B levels were elevated
upon depletion of hCdc14B correlating with increased Cdk1 activity
(Fig. 5B and C) implying that degradation of cyclin B was impaired
upon hCdc14B depletion. Significantly, hCdc14B did not affect
Cdk1/cyclin B activity in vitro (Supp. Fig. S4), suggesting that
hCdc14BdoesnotdirectlytargetCdk1/cyclinB,butratheractivates
proteins and regulators that act upstream of Cdk1/cyclin B.
hCdc14B Dephosphorylates and Inactivates Cdc25
Phosphorylation of Cdc25 promotes activation of Cdk1,
inactivation of Cdc25 correlating with repression of Cdk1 activity
[35]. We therefore investigated whether hCdc14B targets Cdc25
phosphatases, dephosphorylation of Cdc25 proteins by hCdc14B
promoting inactivation of Cdk1 and completion of mitosis. Indeed,
wildtype but not mutant hCdc14B or alkaline phosphatase (CIAP)
efficiently dephosphorylated all three isoforms of Cdc25 in vitro
(Supp. Fig. S5A and B). To prove that hCdc14B also targeted
Cdc25s in vivo, cells co-expressing fl-hCdc14B and the different
isoforms of Cdc25 were arrested in mitosis, and phosphorylation of
Cdc25A, B and C was analyzed on immunoblots. Consistent with
the in vitro data, fl-hCdc14B dephosphorylated all three isoforms of
Cdc25, shifting the hyperphosphorylated to the faster migrating
hypophosphorylated form (Fig. 6A). Notably, siRNA-mediated
depletion of hCdc14B increased the level of hyperphosphorylated,
active Cdc25A, B and C (Fig. 6B) demonstrating a link between
hCdc14B and the phosphorylationlevel of all three Cdc25 isoforms.
hCdc14A has been shown to reverse Cdk1/cyclin B-dependent
phosphorylation of Cdc25A at S115 and S320 [36]. Cdc25A is
phosphorylated at multiple sites, which is required for full Cdc25A
activity during early mitosis [7–8]. To analyze whether the two
human Cdc14 isoforms A and B target the same residues on
Cdc25A, GST-Cdc25A was phosphorylated with Cdk1/cyclin B
immunopurified from mitotic extracts followed by incubation with
either recombinant hCdc14A or hCdc14B (Supp. Fig. S6A). Semi-
quantitative mass spectrometry analysis detected several tryptic
phospho-peptides of Cdc25A that contained S/T-P directed
phosphosites, e.g. serine 18, 40, 88, 116, 261, and 283 (Supp.
Fig. S6B). Comparison of removal of these phosphorylations by
hCdc14A or hCdc14B revealed that one phosphosites, e.g. S40,
was equally dephosphorylated by both isoforms, whereas other
sites were preferentially dephosphorylated by either hCdc14A
(phospho-S116) or hCdc14B (phospho-S88 and phospho-S261)
(Supp. Figure S6B). This result confirms previous data from
Esteban et al [36] showing that hCdc14A dephosphorylates
phospho-serine-116 (equivalent to phospho-serine-115) of
hCdc25A. Moreover, the analysis suggests that hCdc14A- and B
target sites are not fully overlapping.
The functional interplay between Cdc25 and hCdc14B suggests
that the two phosphatases may interact in vivo with each other.
Indeed, co-immunoprecipitation experiments demonstrated that
hCdc14B interacts with all three Cdc25 isoforms (Fig. 6C).
Notably, these interactions are direct as shown by GST-pull down
assays using GST-Cdc25 proteins and in vitro translated hCdc14B
(Supp. Fig. S7). To demonstrate that hCdc14B inactivates Cdc25,
we immunopurified Cdc25A from non-induced and induced
U2OS-fl-hCdc14B cells, and assayed Cdc25A activity by measur-
Table 1. Knockdown of hCdc14B leads to increase of the mitotic index, multinucleation and apoptosis.
Release from G1/S (h) siCtrl: mitotic index (%) siCdc14B-3: mitotic index (%)
8 9.462.7 8.662.5
10 11.363.8 11.064.7
12 56.666.8 51.4612.8
14 28.364.2 50.5610.6
16 16.964.0 47.968.8
Release from G1/S (h) siCtrl: multinucleated cells (%) siCdc14B-3: multinucleated cells (%)
8 0.560.15 6.563.0
Release from G1/S (h) siCtrl: TUNEL positive cells (%) siCdc14B-3: TUNEL positive cells (%)
24 5.461.2 42.668.5
HeLa Kyoto cells transfected with hCdc14B-specific siRNA-3 (siCdc14B-3) or non-targeting siRNAs (siCtrl) were synchronized as shown in Fig. 3A and B. Mitotic cells with
condensed chromatin were counted 8–16 h after release from G1/S, multinucleated cells were counted 8 h after release, and apoptotic cells were visualized by TUNEL
staining 24 h after release. Numbers represent the mean levels (6SD) from three independent experiments comprising counts of 400 cells each.
doi:10.1371/journal.pone.0014711.t001
GFP images represent magnifications of regions marked by rectangles in the phase contrast images. C. Western blot analysis of Cdc27/APC3,
hCdc14B, and b-tubulin in lysates from cells treated with GFP-specific (siGFP) or hCdc14B-specific (siCdc14B-3) siRNAs. The hyperphosphorylated form
of Cdc27/APC3 is indicated. D. hCdc14B depletion induces apoptosis. siRNA transfections and cell synchronization was done as described above.
Before the second thymidine block, equal numbers of cells were seeded on coverslips and apoptosis was monitored 24 h after release from the
second G1/S-arrest in control (siGFP) or hCdc14B-depleted (siCdc14B-3) HeLa Kyoto cells by TUNEL staining (left) and on immunoblots monitoring
caspase-induced proteolysis of PARP-1 (right).
doi:10.1371/journal.pone.0014711.g003
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As shown in Figure 6D, overexpression of fl-hCdc14B reduced
Cdk1-dependent phosphorylation of histone H1 to background
levels, indicating that hCdc14B has inactivated Cdc25A (upper
panel, lane 3). In contrast, Cdc25A isolated from non-induced cells
was twice as active towards stimulating Cdk1 activity as shown by
increased phosphorylation of histone H1 (upper panel, lane 2).
Collectively, the results indicate that hCdc14B inactivates Cdc25
phosphatases, thereby counteracting unscheduled activation of
Cdk1, which in turn promotes completion of mitosis.
Discussion
Though several studies have demonstrated the essential role of yeast
Cdc14 for reversal of Cdk-mediated mitotic phosphorylations and
mitotic exit [16], it remained to be established whether mammalian
Cdc14 homologues serve a similar function. In this study, we present
several lines of evidence showing that human Cdc14B plays a key role
in regulation of Cdk1/cyclin B activity and progression through
mitosis. First, activation of Cdk1/cyclin B and entry into mitosis is
delayed in cells overexpressing hCdc14B, the delay of mitotic entry
correlating with inhibitory phosphorylation of Y15/Cdk1. Second,
hCdc14B dephosphorylated and inactivated mitotic Cdc25 proteins,
the phosphatases that remove inhibitory phosphates from T14/Y15
and activate Cdk1 at G2/M transition. Third, depletion of hCdc14B
by siRNA led to hyperphosphorylation of Cdc25, increased Cdk1
activity, mitotic defects such as delayed anaphase chromosomes and
multipolar spindles, and finally to mitotic arrest and cell death.
Similar to yeast, hCdc14B is associated with nucleolar
chromatin only during interphase, and is released into the
cytoplasm from prometaphase on [19,23,28]. Thus, nucleolar
sequestration represents an evolutionarily conserved mechanism
Figure 4. Downregulation of hCdc14B leads to multipolar mitotic spindles, lagging chromosomes, and binucleation. U2OS cells were
transfected with pTER plasmids expressing two different hCdc14B-specific shRNAs (14B-sh-2, 14B-sh-3) or a control shRNA (Ctrl-sh). 72 h after
transfection, cells were processed for immunofluorescence using anti-alpha-tubulin and Cy3-coupled anti-mouse antibodies (red), and CREST
antiserum (kinetochores) and FITC-coupled anti-human antibodies (green). DNA was stained with Hoechst 33342. Representative examples of
multipolar mitotic cells (A), bipolar mitotic cells with lagging anaphase chromosomes (arrow) (B), and binucleated cells (C) are shown. D. Frequencies
of multipolar spindles and lagging anaphase chromosomes as visualized by staining with anti-alpha-tubulin and CREST. The numbers are derived
from three independent experiments, each count comprising 60 mitotic cells. E. Western blot of hCdc14B after transfection with pTER-ctrl-shRNA
(Ctrl-sh), pTER-Cdc14B-2 (14B-sh-2), and pTER-Cdc14B-3 (14B-sh-3) for 72 h. Decrease of hCdc14B expression was normalized to b-tubulin.
doi:10.1371/journal.pone.0014711.g004
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substrates at defined stages during mitosis and shielding target
proteins from being dephosphorylated during interphase. In
support of this view, elevated levels of hCdc14B perturbed
nucleolar sequestration and delayed entry into mitosis. Notably,
it was recently shown that perturbation of cell cycle progression by
genotoxic stress also induces nucleolar release of hCdc14B
correlating with hCdc14B-dependent activation of APC/C
Cdh1
and G2-arrest [29].
G2/M transition is tightly controlled by a complex mitotic entry
network activation of Cdk1 representing the pivotal event. To
achieve full activity, Cdc25 phosphatases are upregulated at G2/M
by Cdk1- and Plk-dependent phosphorylations, initiating an auto-
amplification loop that ensures rapid mitotic entry. Vice versa,
completion of mitosis relies on inactivation of Cdk1/cyclin B as
well as reversal of mitotic phosphorylations. In mammalian cells
more than one thousand phosphosites are generated by proline-
directed kinases during mitosis, mostly by Cdk1 [37]. The mitotic
phosphatases that dephosphorylate Cdk1 substrates are poorly
characterized. In yeast, Cdc14 is a component of two consecutive
mitotic exit systems, FEAR and MEN that activate Cdc14 leading
to inhibition of mitotic Cdk1 activity and reversal of Cdk1-
dependent phosphorylations [13,38]. In this study we have shown
that hCdc14B plays a pivotal role in dephosphorylating and
inactivating Cdc25 proteins leading to decrease of Cdk1/cyclin B
activity. Inhibition of Cdk1/cyclin B is largely accomplished by
proteasomal degradation of cyclin B through APC
Cdc20 and
APC
Cdh1 [2]. Besides this well-established pathway Cdk1/cyclin B
is also inactivated in a non-proteolytic fashion at onset of anaphase
by transient inhibitory Wee1-mediated phosphorylation of Y15 on
Cdk1 [39]. Since inhibitory phosphorylation on Cdk1 is
counteracted by Cdc25 proteins, phosphatases that target and
repress Cdc25 proteins in mid-mitosis have been postulated [40].
Our data demonstrate that hCdc14B is a candidate phosphatase,
Figure 5. hCdc14B regulates Cdk1/cyclin B activity. A. Overexpression of hCdc14B alters Cdk1/cyclin B activity. Cdk1/cyclin B was
immunopurified from U2OS, U2OS-fl-hCdc14B and U2OS-fl-hCdc14B
SL cells that were synchronized at G1/S (0 h) and released for the indicated times.
Kinase activity was assayed in vitro using Cdk1-specific peptides and
32P-ATP. Values were normalized to the activity of Cdk1/cyclin B in G1/S cells. The
Western blots show the amount of immunoprecipitated cyclin B, Cdk1 and Cdk1/pY15. B. Depletion of hCdc14B increases Cdk1/cyclin B activity. Cells
were transfected with GFP- (siGFP, light bars) or hCdc14B-specific siRNA-2 (siCdc14B-2, dark bars) and arrested by double thymidine block. Kinase
activity of immunopurified Cdk1/cyclin B was assayed in vitro at the indicated times (h) after release from G1/S. The immunoblot on the top shows the
amounts of cyclin B used in the assays. C. Cyclin B is stabilized upon knockdown of hCdc14B. Cells were transfected with siRNAs against GFP (siGFP),
hCdc14B (siCdc14B-2 and siCdc14B-3) or left untransfected (mock), synchronized by double thymidine block, released from G1/S for 16 h and
analyzed on immunoblots.
doi:10.1371/journal.pone.0014711.g005
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PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e14711Figure 6. hCdc14B dephosphorylates Cdc25. A. hCdc14B dephosphorylates Cdc25 in vivo. Immunoblots of nocodazole-arrested HEK293T cells
co-expressing fl-hCdc14B or fl-hCdc14B
SL and HA-Cdc25A, HA-Cdc25B or GFP-Cdc25C. The upper bands correspond to hyperphosphorylated Cdc25
proteins. B. Cdc25 phosphatases are hyperphosphorylated in cells depleted of hCdc14B. HeLa Kyoto cells transfected with control (siCtrl) or hCdc14B-
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and (ii) knockdown of hCdc14B delays inactivation of mitotic
Cdk1 correlating with high level of hyperphosphorylated, active
Cdc25s. Therefore, hCdc14B may act in two ways to inactivate
Cdk1/cyclin B at late mitosis, e.g. by dephosphorylating and
activating the APC co-activator Cdh1 [29] and by enabling Cdk1/
Y15 phosphorylation by Wee1 upon dephosphorylation and
inactivation of Cdc25 phosphatases.
Our results are consistent with the model depicted in Figure 6E.
Entry into mitosis depends on the establishment of a positive
feedback loop involving Cdk1-dependent activation of Cdc25
phosphatases and Cdc25-dependent dephosphorylation of Cdk1
on pT14/pY15. At this stage of the cell cycle, nucleolar
sequestration of hCdc14B prevents premature dephosphorylation
and inactivation of Cdc25s. Transient release from nucleolar
chromatin at prometaphase enables hCdc14B to interact with
Cdc25 proteins. Dephosphorylation by hCdc14B inactivates
Cdc25 phosphatases, allowing de novo phosphorylation of Cdk1
on Y15 and inactivation of Cdk1. Consistently depletion of
hCdc14B prevents timely inactivation of Cdk1/cyclin B, leading to
delay of metaphase and severe mitotic defects. As in human cells a
large number of proteins are phosphorylated by Cdk1/cyclin B
during mitosis [37], prolonged Cdk1 activity and failure of reversal
of Cdk1 phosphorylations will affect a wide range of mitotic
processes. Therefore, depletion of hCdc14B caused severe mitotic
defects, including chromosome missegregation, erroneous mitotic
spindle formation and binucleation.
So far, it was not known whether the hCdc14A and B isoforms
contribute to site-specific dephosphorylation of Cdc25 proteins.
According to our semi-quantitative mass spectrometric analysis
substrate specificity differs between hCdc14A and hCdc14B at
least to some extent. Some phosphorylations of Cdc25A, e.g. pS88
and pS261, were removed by hCdc14B, but were retained after
incubation with hCdc14A. This suggests that the hCdc14 isoforms
target different sites within substrates and are functionally not fully
redundant. Functional analysis of mitotic regulation by phospha-
tases has been hampered by the complex phenotypes associated
with inactivation of mitotic phosphatases, making it difficult to
distinguish between primary and secondary effects [38]. Never-
theless, the phenotypes resulting from knockdown of hCdc14B or
hCdc14A are distinct and consistent with hCdc14A playing
primarily a role in centrosome splitting, and hCdc14B promoting
primarily progression through mitosis and chromosome segrega-
tion.
Studies on the role of hCdc14B in cell cycle regulation have
been controversial, depending on the experimental systems used,
e.g. depletion by RNAi, overexpression or gene knockout in
cultured cell lines. hCdc14B has been implicated in centriole
amplification [30], mitotic exit [25], M/G1 transition [32], G2-
DNA damage check point activation [29], DNA repair [31],
bundling and stabilizing microtubules, and assembly of the mitotic
spindle [28]. In contrast to our results, a recent study by Berdougo
et al [40] showed no obvious mitotic defects in human colorectal
carcinoma HCT116 cells in which the hCdc14B gene has been
genetically inactivated. This obvious discrepancy may be due to
mechanisms that established during selection of the somatic
knockout cells compensating loss of hCdc14B. Requirement for
hCdc14B may also vary between different cell lines. We observed
that hCdc14B levels are high in HeLa cells but low in HCT116
cells (unpublished data). A recent RNAi screen identified PP2A-
B55a as a phosphatase that promotes late mitosis and mitotic exit
suggesting that other phosphatases may compensate loss of
hCdc14B in a cell-type specific manner [41]. In addition,
hominoids contain another hCdc14B-like gene, known as
hCdc14C [42]. Therefore it cannot be ruled out, that other
phosphatases functionally replace hCdc14B in different cell lines to
trigger inactivation of Cdk1 in mid mitosis. Notably, expression of
hCdc14C is inhibited by the siRNAs used in our study but not by
the hCdc14B knockout strategy used by Berdougo et al [40].
Therefore, the differences in mitotic phenotypes may be attributed
to hCdc14C replacing the function of hCdc14B. This would also
explain the observation that Cdc14B-specific antibodies detected
the hCdc14 protein in wildtype as well as in Cdc14B
2/2 cells [40].
Clearly, further systemic approaches are required to identify
additional physiological substrates of hCdc14B and to elucidate
the processes that link hCdc14B activity to cell division.
Materials and Methods
Plasmids and Antibodies
Human cDNAs encoding hCdc14A and hCdc14B (accession
numbers AF064102.1 and AF064104.1) were cloned into
pTOPO-CR2.1 (Clontech), pRc/CMV-Flag, pET-28a, pGEX-
2T, and pcDNA4/TO (Invitrogen). Point mutations (C326S and
A328L in hCdc14B
SL) within the catalytic domain of hCdc14B
were introduced by PCR. All PCR-generated fragments were
verified by DNA sequencing. Plasmids encoding Cdc25A, B and C
have been described [9,43–44]. The shRNA expression vector
pTER
+ [45, Reference S2] was used to insert duplex oligonucle-
otides corresponding to different regions of the hCdc14B coding
region (see Table S2).
Antibodies used were anti-Cdc14B (Zymed), anti-Flag (M2,
Sigma), anti-HA (12CA5), anti-GFP (sc-8334 FL), anti-actin (C4),
anti-H3-phospho-Ser10 (Upstate), anti-Cdk1 (sc-054), anti-cyclin
B (sc-GNS1), anti-cyclin E (sc-C19), anti-cyclin A (Oncogene, AB-
2), anti-cyclin D (sc-HD11), anti-Cdk1 phospho-specific (Calbio-
chem), anti-Cdc25A (sc F-6), anti-Cdc25B (sc C-20), anti-Cdc25C
(sc C-20), anti-APC3/Cdc27 (BD Biosciences), anti-tubulin (Sigma
B-5-1-2), and CREST autoimmune antibodies. Polyclonal anti-
bodies against hCdc14A produced in rabbits were purified using
GST-hCdc14A coupled to Affigel 10 (Bio-Rad).
Cell Culture and Transfections
HeLa cells expressing H2B-GFP (Kyoto) were cultured in
DMEM/10% FCS containing 500 mg/ml of G418. U2OS and
293T cells were obtained from ATCC. To generate U2OS-fl-
specific siRNA-3 (siCdc14B-3) were released from G1/S for 18 h, and analyzed on Western blots. C. hCdc14B interacts with Cdc25 isoforms in vivo.
Immunoblots showing co-precipitation of Cdc25 isoforms with fl-hCdc14B
SL from 293T cells co-expressing HA-Cdc25A, HA-Cdc25B, GFP-Cdc25C, and
fl-hCdc14B
SL. D. Overexpression of hCdc14B leads to inactivation of Cdc25A. Cdc25A was immunoprecipitated from doxycyclin-treated (dox) or
untreated U2OS-fl-hCdc14B cells, incubated with Cdk1/cyclin B from S-phase cells, and kinase activity of Cdk1/cyclin B was monitored by in vitro
phosphorylation of histone H1 (top). As a control, activation of Cdk1/cyclin B was monitored using recombinant GST-Cdc25A (bottom). Quantification
of histone H1 phosphorylation was performed with a PhosphorImager and is shown below. E. Model depicting the role of hCdc14B during mitosis.
Entry into mitosis requires a positive feedback loop, involving Cdk1-dependent activation of Cdc25 phosphatases and Cdc25-dependent
dephosphorylation of Cdk1 on pT14/Y15. Before onset of mitosis, hCdc14B is sequestered within the nucleolus, preventing premature
dephosphorylation and inactivation of Cdc25 proteins. From prometaphase until late mitosis, hCdc14B is released from nucleolar chromatin, leading
to inactivation of Cdc25s, which triggers inhibitory phosphorylation of Cdk1 and inactivation of Cdk1/cyclin B.
doi:10.1371/journal.pone.0014711.g006
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6TR (Clontech) and pcDNA/TO-fl-hCdc14B or pcDNA/TO-fl-
hCdc14B
SL. Clones were selected in tetracycline-free medium
supplemented with zeocin (250 mg/ml) and blasticidin (5 mg/ml).
For fl-hCdc14B expression, cells were treated with doxycyclin
(1 mg/ml). Cells were synchronized by a double thymidine-block,
and fl-hCdc14B expression was induced by addition of doxycyclin
8 h before cells were released from the second thymidine-block.
Cells transfected with shRNA expression plasmids were selected in
the presence of zeocin (250 mg/ml) [45]. siRNA duplexes (40–
100 nM) were reverse transfected with lipofectamin 2000
(Invitrogen). siRNA and shRNA sequences are given in Table
S1 and S2. Cdc14 transcripts were measured by reverse
transcription using random hexamer primers and quantitative
real-time PCR (LightCycler 480, Roche) essentially as described
[46]. Data were normalized to the level of actin-mRNA. Primer
sequences are given in Table S3.
Fractionation of Cell Extracts
Cells were fractionated as described [47] with minor modifica-
tions. Buffer B contained 10 mM HEPES, pH 7.9, 150 mM
NaCl, 3 mM EDTA, 0.2 mM EGTA, and 1 mM DTT.
Chromatin-bound proteins were extracted with SDS-sample
buffer supplemented with 2 mM MgCl2 0.5 mM PMSF and
protease inhibitors (Complete, Roche). After sonication (Biorup-
tor), samples were treated with benzonase (10 U/100 ml, 15 min
at RT) and clarified by centrifugation.
Immunocytochemistry
Cells grown on poly-lysine coated coverslips were fixed with 2%
paraformaldehyde, permeabilized with ice-cold methanol, and
incubated with the indicated first antibodies and fluorescence-
labelled secondary antibodies (Invitrogen, Dianova). DNA was
stained using Hoechst 33342. Apoptotic cells were detected by
TUNEL assay using the In Situ Cell Death Detection Kit (Roche).
Purification of Recombinant Phosphatases
GST and recombinant GST-tagged proteins were expressed in
E. coli Codon Plus-RP cells (Stratagene), affinity-purified over
glutathione-Sepharose and eluted according to standard proce-
dures.
Protein Interaction Assays
Purified GST-tagged isoforms of Cdc25 were incubated with in
vitro translated
35S-labeled hCdc14B for 4 h at 4uC in buffer AM-
120 (120 mM KCl, 20 mM Tris-HCl pH 7.9, 5 mM MgCl2,
0.2 mM EDTA, 10% glycerol, 0.5 mM EDTA), supplemented
with 0.2% NP-40 and protease inhibitors (Complete, Roche). For
co-immunoprecipitation of hCdc14B and Cdc25s, 1.5610
6 U2OS
cells were transfected with the corresponding expression plasmids,
treated with 10 mM MG132 for 6 h, and lysed in buffer AM-120
containing 0.5% NP-40, 10% glycerol, DNase I (200 U/ml),
RNase A (100 mg/ml), and protease inhibitors (Complete, Roche).
After incubation with 10 ml (1:1 slurry) of anti-Flag (M2)-agarose
(Sigma), immunoprecipitated proteins were analyzed on immuno-
blots.
Enzymatic Assays
Cdk1/cyclin B and Cdc25 activity were analyzed as described
[48,49]. Cdc14B activity was assayed using pNPP as substrate.
Briefly, hCdc14B was incubated for 60 min at 30uCi n
phosphatase assay buffer (50 mM Tris-HCl, pH 6.8, 2 mM
EDTA, 0.01% Triton-X-100, 2% glycerol, 150 mM NaCl,
5 mM DTT) containing 20 mM p-nitrophenylphosphate (pNPP).
Substrate turnover was measured in a spectrophotometer at
405 nm. To assay dephosphorylation of Cdc25, bead-bound
GST-Cdc25 proteins were phosphorylated with immunopurified
Cdk1/cyclin B complexes [48] or by incubation with extracts from
mitotic HeLa cells (30 mg protein, 30 min, 30uC) in 50 mM Tris-
HCl, pH 7.5, 10 mM MgCl2, 1 mM EGTA, 20 mM b-glycero-
phosphate, 1 mM DTT, 10 mM ATP and 5 mCi
32P-ATP. After
washing,
32P-labeled GST-Cdc25 isoforms were incubated for
45 min at 37uC with equal enzymatic units of recombinant
hCdc14B, hCdc14B
SL or CIAP (Roche) in phosphatase assay
buffer.
Cdc25A activity was measured essentially as described [49].
Cdk1/cyclin B was immunopurified from S-phase cells using anti-
cyclin B antibodies. U2OS-fl-hCdc14B cells were cultured in the
absence or presence of doxycyclin (2 mg/ml, 8 h). Cdc25A was
immunoprecipitated from equal amounts of cells and incubated
with bead-bound Cdk1/cyclin B in 100 ml of phosphatase assay
buffer (15 min, 30uC). Control reactions contained the same
amount of cell lysate and rabbit IgGs (Dianova). After washing,
beads were incubated for 15 min at 30uCi n5 0ml histone H1
kinase assay buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2,
1 mM DTT, 5 mg histone H1 (Roche), 50 mM ATP, 5 mCi
32P-
ATP), subjected to SDS-PAGE, and radioactive proteins were
detected by PhosphorImaging.
Analysis of Phosphopeptides by Mass Spectrometry
GST-Cdc25A was phosphorylated with immunopurified Cdk1/
cyclin B for 1 h at 30uC in kinase buffer supplemented with 50 mM
ATP in the absence or presence of radioactive
32P-ATP. GST-
Cdc25A beads were washed three times in high salt buffer (20 mM
Tris-HCl, pH 7.9, 1 M KCl, 5 mM MgCl2, 0.2 mM EDTA, 10%
glycerol, 0.5 mM DTT), equilibrated twice in phosphatase assay
buffer, and incubated for 1 h at 30uC in phosphatase assay buffer
containing equal phosphatase activities (1.2 U) of hCdc14A or
hCdc14B, or no phosphatase for control. GST-Cdc25A beads
were again washed in high salt buffer, equilibrated in 50 mM
ammonium bicarbonate, and proteins were digested with trypsin
overnight at 37uC. The resulting tryptic peptides were analyzed by
nanoLC ESI-MS/MS. ESI-MS/MS analysis and database search
were performed essentially as described [50].
Supporting Information
References S1
Found at: doi:10.1371/journal.pone.0014711.s001 (0.04 MB
DOC)
Figure S1 Doxycyclin (dox)-induced expression of fl-hCdc14B
and fl-hCdc14BSL in clonal U2OS-fl-hCdc14B cells. Cells were
synchronized at G1/S by a double thymidine-block and released
in the presence of dox (1 mg/ml) for the indicated time (h). Fl-
hCdc14B expression was analyzed by Western blotting using anti-
Cdc14B antibodies.
Found at: doi:10.1371/journal.pone.0014711.s002 (0.96 MB EPS)
Figure S2 Prolonged overexpression of fl-hCdc14B in U2OS
cells increases the cell doubling time. A. Fl-hCdc14B expression
was induced in three different clonal U2OS-fl-hCdc14B cell lines
by doxycyclin (1 mg/ml), and fl-hCdc14B expression was
monitored over 48 h by Western blotting. B. Overexpression of
fl-hCdc14B in U2OS-fl-hCdc14B cell lines prolongs the cell
doubling time. Equal amounts of U2OS-fl-hCdc14B cells of clones
6, 7, and 13 were seeded in 6 cm culture dishes and incubated in
the absence or presence of doxycyclin (dox, 1 mg/ml). After 56 h
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amount of cells (6SD) obtained from the non-induced culture
(gray bars) and the induced culture (black bars). The values are
derived from 3 independent experiments.
Found at: doi:10.1371/journal.pone.0014711.s003 (1.88 MB EPS)
Figure S3 Depletion of hCdc14B leads to bi- and multi-
nucleation of cells. Cells transfected with GFP-specific siRNA
(siGFP) or hCdc14B-siRNA-3 (siCdc14B-3) were analyzed for
multinucleated cells. Representative phase contrast images are
shown. Arrows indicate multinucleated cells.
Found at: doi:10.1371/journal.pone.0014711.s004 (2.79 MB EPS)
Figure S4 hCdc14B downregulates Cdk1/cyclin B activity in
vivo but not in vitro. A. HEK293T cells overexpressing fl-
hCdc14B or fl-hCdc14BSL were treated with nocodazole for 22 h,
and the kinase activity of immunopurified Cdk1/cyclin B was
measured in vitro in the presence of Cdk1-specific peptides as
described in Figure 5A. B. hCdc14B does not affect the activity of
Cdk1/cyclin B in vitro. Cdk1/cyclin B activity was determined
after incubation with GST (1 mg) or GST-hCdc14B (1 and 2 mg)
for 30 min at 30uC (left panel). Right panel: In vitro phosphatase
assay showing the activity of GST-hCdc14B in the presence of 20
mM pNPP as substrate. Values are from three independent
experiments (mean 6SD).
Found at: doi:10.1371/journal.pone.0014711.s005 (0.40 MB EPS)
Figure S5 hCdc14B dephosphorylates Cdc25 proteins in vitro.
A. GST-tagged Cdc25A, B, and C were immobilized on
Glutathione-Sepharose and phosphorylated in vitro using extracts
from mitotic HeLa cells and 32P-ATP. Phosphorylated Cdc25 was
incubated with increasing amounts of GST-hCdc14B or the
corresponding activity of calf intestine alkaline phosphatase (CIAP,
0.025, 0.05, and 0.125 U), or was left untreated (-). After SDS-
PAGE, GST-Cdc25 and GST-hCdc14B proteins were stained
with Coomassie Blue (C panels), and the level of Cdc25
phosphorylation was monitored by PhosphorImaging (32P panels).
B. GST-tagged Cdc25A and B were immobilized on Glutathione-
Sepharose and phosphorylated in vitro using Cdk1/cyclin B
complexes purified from Sf9 cells and 32P-ATP. After washing,
the beads were incubated for 45 min at 30uC with 1 mg of GST-
hCdc14B, 1 mg of the phosphatase-dead mutant GST-
hCdc14BSL, or left untreated. Reactions were stopped, samples
separated by 8% SDS-PAGE, and stained with Coomassie Blue
(bottom panels). 32P-labelled Cdc25 (top panels) was detected by
autoradiography.
Found at: doi:10.1371/journal.pone.0014711.s006 (2.03 MB EPS)
Figure S6 Mass spectrometry-based identification of GST-
Cdc25A peptides phosphorylated by Cdk1/cyclin B and dephos-
phorylated by hCdc14A/B. Recombinant GST-Cdc25A was
phosphorylated in vitro by Cdk1/cyclin B immunopurified from
mitotic HeLa cell extracts in the absence or presence of 32P-ATP,
followed by incubation with recombinant hCdc14A or B. A. 32P-
phosphorylated GST-Cdc25A was incubated with 1.2 or 0.6 U of
recombinant His-hCdc14A or B or was left untreated (-).
Following SDS-PAGE, GST-Cdc25A phosphorylation was mon-
itored by PhosphorImaging (left panel). Phosphatase activity of
recombinant His-hCdc14B (white bars) and His-hCdc14A (grey
bars) was determined in vitro using pNPP as substrate (right
panel). Values are derived from three independent assays (mean
6SD). B. Summary of tryptic GST-Cdc25A phospho-peptides
identified with nanoLC ESI-MS/MS and Mascot search engine
(top panel). Schematic presentation of the relative abundance of
GST-Cdc25A phosphopeptides in the absence of hCdc14A or B
(black bar) and after incubation with hCdc14B (white bar) or
hCdc14A (grey bar).
Found at: doi:10.1371/journal.pone.0014711.s007 (0.53 MB EPS)
Figure S7 hCdc14B interacts with all three isoforms of Cdc25.
GST or GST-Cdc25A, B, and C were incubated for 4 h at 4uC
with 35S-labeled fl-hCdc14B. Bead-bound proteins were separat-
ed by SDS-PAGE and visualized by PhosphorImaging. The first
lane shows 10% of the input proteins.
Found at: doi:10.1371/journal.pone.0014711.s008 (0.37 MB EPS)
Table S1 Sequences of the siRNAs used in this study. All
sequences are written from 5 to 3 orientation. Chemically
synthesized siRNA duplexes were obtained from Eurogentec
(siCdc14B), MWG (siGFP), and Dharmacon (siCdc14A and siCtrl
corresponding to the non-targeting siRNA pool 1). Sequences of
the non-targeting siRNA pool 1 are available from Dharmacon.
Found at: doi:10.1371/journal.pone.0014711.s009 (0.03 MB
DOC)
Table S2 Sequences of shRNAs used in this study. DNA
oligonucleotides (given in 5 to 3 orientation) encoding sense and
antisense strands were cloned into the shRNA expression vector
pTER as described [S2]. shRNA targeting sequences are
highlighted in bold.
Found at: doi:10.1371/journal.pone.0014711.s010 (0.03 MB
DOC)
Table S3 Sequences of primers used for RT-qPCR in this study.
Found at: doi:10.1371/journal.pone.0014711.s011 (0.03 MB
DOC)
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